Lincoln Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2025 ,inter alia, to consider and approve Audited (standalone and consolidated) financial results of the Company for the quarter and year ended on March 31, 2025.